Compound Detail
CHEMBL4162891
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4162891 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DVYWFGLLFVYNON-UHFFFAOYSA-N |
| Parent Compound | CHEMBL4300077 |
| Active Moiety | CHEMBL4300077 |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
318.3
MW (Da)
1.30
ALogP
6
HBA
3
HBD
116.8
PSA (Ų)
0.78
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.77
IC50 1 meas. best 6.14
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Egl nine homolog 1 CHEMBL5697 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
| Egl nine homolog 1 CHEMBL5697 | EC50 | 4.77 | 4.77 | 17000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Egl nine homolog 1 | IC50 | = | 720.0 | nM | 6.14 | Inhibition of human HIF-PHD2 assessed as reduction in HIF1-alpha binding to VBC ... | 29259755 |
| Egl nine homolog 1 | EC50 | = | 17000.0 | nM | 4.77 | Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release afte... | 29259755 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29259755 | 10.1021/acsmedchemlett.7b00404 | Egl nine homolog 1 | 2 |
| 29259755 | 10.1021/acsmedchemlett.7b00404 | ADMET | 1 |
| 29259755 | 10.1021/acsmedchemlett.7b00404 | Mus musculus | 1 |
Data from ChEMBL 36 via Core Engine